Comparison Chart Clarity Pharmaceuticals Ltd

Stocks

CU6

AU0000165375

Biotechnology & Medical Research

Market Closed - Australian S.E. 09:10:10 28/10/2026 +04			5-day change	1st Jan Change
1.565 ^AUD	+0.97%		-12.08%	-53.70%

10-27	Clarity Pharmaceuticals Achieves Target Enrollment In Registrational Phase III CLARIFY Trial Of 64Cu-SAR-bisPSMA For Prostate Cancer Imaging	CI
10-27	Clarity Pharmaceuticals Achieves Participant Target in Prostate Cancer Diagnostic Trial	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	CLARITY PHARMACEUTICALS LTD	Bio Therapeutic Drugs	+0.97%	-12.08%	-53.70%	-65.75%	+40.36%	407M